Article
Engineering novel AAV capsids by global de-targeting and subsequent muscle-specific tropism in mice and NHPs
2025-05-19
Abstract excerpt
Recombinant adeno-associated viral (rAAV) vectors are a potent tool, but their clinical application is restricted by insufficient target tissue transduction and liver toxicity. We employed a novel two-step engineering strategy to create novel rAAV capsids with global tissue de-targeting, then produced strong tissue-specific expression by adding a peptide sequence. We created a novel capsid, AAV.Zero1, with globall...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 69105701-a2c0-518f-86ba-533cfd9d30fe
- DOI
- 10.1101/2025.05.19.654800
